Stock Rich List
#731 on the corporate holders of 809 holders

Biotechnology Value Trading Fund OS LP

Director at Kymera Therapeutics; Insider at Cullinan Therapeutics; Director at Olema Oncology.

$64.4M
in disclosed stock, −$816K (−1.25%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
731st of 809
Companies held
6
Largest holding
KYMR, 89.7% of total
Latest SEC filing
Jun 24, 2026

What the $64.4M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Kymera Therapeutics KYMR
Common Stock, $0.0001 par value
Directly353,412$119.39$42.2M65.5%Form 4, Jun 24, 2026
Kymera Therapeutics KYMR
Common Stock, $0.0001 par value
Indirectly (see filing footnote)130,645$119.39$15.6M24.2%Form 4, Jun 24, 2026
Cullinan Therapeutics CGEM
Common Stock
Directly319,415$9.07$2.9M4.5%Form 4, May 13, 2022
Olema Oncology OLMA
Common stock, $0.0001 par value
Directly
Reported jointly by 2 insiders; split evenly
262,076$7.15$1.9M2.9%Form 4, Sep 12, 2023
Olema Oncology OLMA
Common stock, $0.0001 par value
Indirectly (see filing footnote)99,556$7.15$712K1.1%Form 4, Sep 14, 2023
Verastem VSTM
Common Stock
Directly82,863
split-adjusted
$6.86$568K0.9%Form 3, Jan 25, 2022
Immunic IMUX
Common Stock, $0.0001 par value
Directly42,763
split-adjusted
$7.39$316K0.5%Form 3, Feb 17, 2026
Eledon Pharmaceuticals ELDN
Common Stock, $0.001 par value
Directly145,029$1.90$276K0.4%Form 4, May 5, 2023

Share counts are the amounts Biotechnology Value Trading Fund OS LP reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
728Pioneer Acquisition 1 Sponsor Holdco LLC
10% owner, Pioneer Acquisition I
$65.9M$0 (0.00%)
729Rosalind Advisors, Inc.
Director, Delcath Systems
$65.2M−$1.6M (−2.34%)
730venBio Global Strategic Fund IV, L.P.
10% owner, Attovia Therapeutics
$65.1M+$209K (+0.32%)
731Biotechnology Value Trading Fund OS LP
Director, Kymera Therapeutics
$64.4M−$816K (−1.25%)
732Transcontinental Realty Investors INC
10% owner, Income Opportunity Realty Investors
$64.0M$0 (0.00%)
733Paddington Partners 88 LLC
CEO, Quantum Leap Acquisition
$63.6M−$190K (−0.30%)
734Union Investments & Development Ltd.
10% owner, Xtend AI Robotics
$63.5M+$4.6M (+7.83%)

Other Kymera Therapeutics insiders

All KYMR insiders

Questions

How much stock does Biotechnology Value Trading Fund OS LP own?

Biotechnology Value Trading Fund OS LP holds $64,434,336 in listed stock based on SEC filings and current prices, mostly Kymera Therapeutics (KYMR). That ranks 731st on the Stock Rich List.

Is this Biotechnology Value Trading Fund OS LP's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with SEC filer 1233840.